Ysios Capital
Venture Capital. Pre-Seed, Series A, Series B.
- Stages
- Pre-Seed, Series A, Series B
- Focus
- Health & Bio
- Invests in
- Europe, US
- Offices
- Barcelona, Spain; San Sebastián, Spain
- Founded
- 2008
- Latest fund
- €100M
- Website
- ysioscapital.com
- Elsewhere
- LinkedIn · X
About
Ysios Capital's managing partners are Joël Jean-Mairet, Julia Salaverría, Karen Wagner and Joan Perelló; Cristina Garmendia is general partner, and Jordi Xiol, Guillem Laporta and Arturo Urrios are partners, supported by a group of venture partners. Besides its main office, the firm has a team in San Sebastián. It invests through its BioFund series. In 2026 it added InceptionBio, a vehicle led by Perelló and Urrios that builds companies around research from universities and research centres and brings in international assets for development. Ysios also advises Telescope Biotech Fund, a listed fund managed by Andbank Wealth Management. It describes itself as a supportive, hands-on investor. It judges each deal mainly on the management team and the strength of the science, ideally backed by preclinical models or first clinical data, and rates companies with Y-mpact, an in-house score covering innovation, social burden of disease and governance.
Notable investments
How to pitch
Ysios takes submissions from life sciences companies developing innovative therapeutics through the 'Submit a project' form on its contact page. The form asks for name, company, email, phone, industry (therapeutics, medical device, diagnostics, digital therapeutics or other), country and comments, and recommends uploading a non-confidential company presentation.
Last checked 13 November 2026. Something wrong or out of date? Write to hi@schub.tech.
Previous: Yellow VCNext: Zeno Partners
Building a company in Europe? Schub invests €25k for 2% and gives you a weekly 1:1 with a founder coach.
Apply to Schub